In our quest to elucidate the mechanisms for docetaxel resistance in prostate cancer, we initiated our analysis by examining the RNA expression profiles of three prostate cancer organoids—namely, MSK-PCa3, MSK-PCa7, and PM154. The gene discussed is PCA3; the disease is prostate carcinoma.